HEART TRANSPLANT REJECTION
Clinical trials for HEART TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new HEART TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for HEART TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a once-daily pill prevent heart transplant rejection better than the standard twice-daily regimen?
Disease control CompletedThis study tested whether a once-daily anti-rejection medication (Envarsus) works as well as the standard twice-daily drug (Prograf) in heart transplant patients. Researchers looked at rates of organ rejection and graft failure, and whether taking the drug once a day helps patien…
Matched conditions: HEART TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Heart transplant clue: TTV virus levels may warn of rejection or infection
Knowledge-focused CompletedThis study looked at 60 heart transplant patients to see if the level of a common virus called TTV in their blood could predict problems like organ rejection or serious infections in the first year after transplant. Researchers measured TTV levels monthly and tracked any rejectio…
Matched conditions: HEART TRANSPLANT REJECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 10:30 UTC